KURA Latest Headlines

Analysts Conflicted on These Healthcare Names: Aveanna Healthcare Holdings (AVAH), Kura Oncology (KURA) and Hyperion DeFi (HYPD)

at www.tipranks.com (Mon, 8-Jun 8:00 AM)

Kura Oncology’s Darlifarnib Combo Achieves 77% Tumor Shrinkage Rate in KRAS G12C-Mutant Cancers

Market Chameleon (Tue, 26-May 7:54 AM)

Kura Oncology’s ASCO Summit Spotlight: Upcoming TD Cowen Presentation Highlights Growing Pipeline Momentum

Market Chameleon (Wed, 20-May 11:46 AM)

Kura Oncology’s Darlifarnib Combo Achieves 44% Response Rate in Difficult-to-Treat RCC—Signals Potential to Overcome Drug Resistance

Market Chameleon (Fri, 17-Apr 11:46 AM)

Darlifarnib Plus Cabozantinib Shows Strong Response Rates in Heavily Pretreated Renal Cell Carcinoma—44% ORR and 94% DCR Stand Out

Market Chameleon (Fri, 17-Apr 7:28 AM)